Escitalopram to Fluvoxamine Switching Strategy
A switch from one SSRI to another SSRI is typically performed as a direct switch. [1] This strategy involves stopping escitalopram and starting fluvoxamine the following day. [1] Clinical monitoring should focus on withdrawal symptoms, serotonin syndrome, and relapse. [2]
Medication Selection Algorithm
The SSRI-to-SSRI approach is determined by excluding switches involving fluoxetine. [1]
- Direct switch is normally possible for SSRI-to-SSRI transitions from any SSRI other than fluoxetine. [1]
- Cross-tapering is not required for the SSRI-to-SSRI transition described. [1]
Switching Sequence
A direct switch sequence is recommended. [1]
- Day 0: Escitalopram is stopped. [1]
- Day 1: Fluvoxamine is started. [1]
Monotherapy Versus Combination Therapy During Transition
Serotonergic overlap increases the risk of serotonin syndrome. [2] A direct switch minimizes concomitant exposure compared with a cross-taper strategy. [2] Concurrent SSRI+SSRI exposure should be avoided unless specifically planned with close monitoring. [2]
Initiation Thresholds and Timing
Treatment effect from antidepressant changes may take 1–2 weeks. [2] If no benefit is seen after 4–6 weeks, the medication regimen should be reviewed. [2]
Monitoring Schedules During and After Switching
A review is recommended within 2 weeks after starting the new antidepressant for depression. [2] A review at 1 week is recommended for persons with suicide risk or age 18–25. [2] A review should occur again as often as needed, but no later than 4 weeks after initiation. [2]
Common Pitfalls to Avoid
Withdrawal symptoms can occur after stopping the prior antidepressant. [2] Symptoms that may occur include dizziness, headaches, “brain zaps,” unsteady gait, palpitations, tremor, and gastrointestinal disturbances. [2] Serotonin syndrome is uncommon but potentially life-threatening. [2] Serotonin syndrome manifestations include autonomic dysfunction (tachycardia, blood pressure changes, hyperthermia, sweating, shivering, diarrhea), neuromuscular hyperactivity (tremor, rigidity, myoclonus, clonus, hyperreflexia), and altered mental state (agitation, confusion, mania, coma). [2]
Treatment Goals After Switching
Symptom response should be assessed during early follow-up based on clinical status and side-effect burden. [2] Relapse risk should be assessed after the medication change because antidepressant treatment may be needed for 6 months or longer if relapse risk is higher. [2]